Mexiletine

Mexiletine is a Class Ib antiarrhythmic agent administered orally and indicated for patients with ventricular arrhythmias.

Indications

  • It is utilized for the management of patients with ventricular tachycardias, typically in combination with other pharmacological agents such as beta-blockers and amiodarone. Mexiletine is frequently used in patients with ischemic or dilated cardiomyopathy who experience recurrent episodes of ventricular tachycardia, serving as an adjunctive therapy to already established regimens of beta-blockers and amiodarone.
  • Mexiletine has also been deployed in patients with arrhythmias associated with Long QT Syndrome Type 3 (LQT3).

Adverse Effects

  • Approximately 40% of patients require drug discontinuation due to the onset of adverse effects, which include tremor, dysarthria, dizziness, paresthesia, diplopia, nystagmus, confusion, nausea, and dyspepsia.
  • Cardiovascular adverse effects are rare and primarily include hypotension and bradycardia.
2026-11-18T22:39:58+00:00